AEON Biopharma, Inc. (NASDAQ:AEON) Sees Significant Decline in Short Interest

AEON Biopharma, Inc. (NASDAQ:AEON – Get Free Report) was the target of a significant decline in short interest in the month of August. As of August 15th, there was short interest totaling 254,000 shares, a decline of 22.6% from the July 31st total of 328,300 shares. Approximately 2.8% of the shares of the company are […]

Leave a Reply

Your email address will not be published.

Previous post Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Growth in Short Interest
Next post Abacus Life, Inc. 9.875% Fixed Rate Senior Notes due 2028 (NASDAQ:ABLLL) Sees Significant Growth in Short Interest